Skip to content

Clinical trials

Completed Multiple Sclerosis, Relapsing-Remitting trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Not applicable Status: Completed Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20112
20124
20135
20141
20154
20162
20176
20184
20194
20209
20211
20221
20235
20245
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University3
Universidad de Almeria3
Cairo University2
Charite University, Berlin, Germany2
Hacettepe University2
Institut National de la Santé Et de la Recherche Médicale, France2
Terry L. Wahls2
University Hospital, Caen2
University of Missouri, Kansas City2
Universitätsklinikum Hamburg-Eppendorf2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting59
Multiple Sclerosis31
Fatigue16
Multiple Sclerosis, Chronic Progressive7
Cognitive Dysfunction4
Demyelinating Diseases3
Nervous System Diseases3
Anxiety Disorders2
Autoimmune Diseases of the Nervous System2
Demyelinating Autoimmune Diseases, CNS2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.